eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2018
vol. 14
 
Share:
Share:
more
 
 
abstract:
Clinical research

Response to an oral fat load and effects on lipid profile, glycemia and high-sensitivity C-reactive protein after soybean extract consumption

Giuseppe Derosa, Angela D’Angelo, Davide Romano, Pamela Maffioli

Arch Med Sci 2018; 14, 4: 760–765
Online publish date: 2017/10/24
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The aim of this study was to evaluate the response in terms of lipid profile, glycemia and high-sensitivity C-reactive protein after an oral fat load (OFL) with a non-dairy cheese cream containing fermented soybean extract soy, compared to a dairy cheese.

Material and methods
One hundred twenty-four healthy subjects underwent an OFL performed using a mixture containing non-dairy cheese cream, containing 75% fermented soybean extract (Valsoia Lo spalmabile), or a dairy cheese cream.

Results
During the OFL, total cholesterol and triglycerides at 6 h were lower with non-dairy cheese cream containing fermented soybean compared to dairy cheese cream. The value of low-density lipoprotein cholesterol recorded at 6 h with the active treatment was lower than the one recorded at the same time with the dairy cheese cream. A decrease of high-density lipoprotein cholesterol (HDL-C) was recorded with the dairy cheese cream, but not with the active treatment; moreover, the HDL-C value recorded with the active treatment was higher than the one observed with the dairy cheese cream. There was an increase of high-sensitivity C-reactive protein (hs-CRP) at 3, 6, and 9 h compared to 0 h with the dairy cheese cream, but not with the active treatment. The hs-CRP value observed with the active treatment was lower than the one observed with the dairy cheese cream.

Conclusions
A non-dairy cheese cream, containing 75% fermented soybean extract, caused a minor increase of lipid profile and of hs-CRP during OFL compared to a dairy cheese cream in healthy subjects.

keywords:

cheese cream, lipid profile, non-dairy cheese cream, soybean extract

references:
McBride PE. Triglycerides and risk for coronary heart disease. JAMA 2007; 298: 336-8.
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
Groot PH, van Stiphout WA, Krauss XH, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991; 11: 653-62.
Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappiè S, Catapano AL. Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab 2004; 89: 2946-50.
Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994; 106: 83-97.
Parks EJ. Recent findings in the study of postprandial lipemia. Curr Atheroscler Rep 2001; 3: 462-470.
Van Oostrom AJ, Alipour A, Plokker TW, Sniderman AD, Cabezas MC. The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 2007; 190: 167-73.
Peake PW, Kriketos AD, Campbell LV, Charlesworth JA. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. Int J Obes 2005; 29: 429-35.
Derosa G, Ferrari I, D’Angelo A, et al. Oral fat load effects on inflammation and endothelial stress markers in healthy subjects. Heart Vessels 2009; 24: 204-10.
Derosa G, Ferrari I, D’Angelo A, et al. Effects of a standardized oral fat load on vascular remodelling markers in healthy subjects. Microvasc Res 2010; 80: 110-5.
Bhagat U, Das UN. Potential role of dietary lipids in the prophylaxis of some clinical conditions. Arch Med Sci 2015; 11: 807-18.
Khan N, Akhtar MS, Khan BA, Braga Vde A, Reich A. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats. Arch Med Sci 2015; 11: 1261-71.
Ursoniu S, Sahebkar A, Serban MC, Banach M. Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials. Arch Med Sci 2015; 11: 253-66.
Sahebkar A, Serban MC, Gluba-Brzózka A, et al. Lipid-modifying effects of nutraceuticals: an evidence-based approach. Nutrition 2016; 32: 1179-92.
Patti AM, Toth PP, Giglio RV, et al. Nutraceuticals as an important part of combination therapy in dyslipidaemia. Curr Pharm Des 2017; 23: 2496-503.
Manzoni C, Lovati MR, Agostinelli P, Sirtori CR. Studies on the mechanism of the cholesterol lowering activity of soy proteins. Pharmacol Res 1990; 22: 300.
Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of a health claim related to soy protein and reduction of blood cholesterol concentrations pursuant to Article 14 of the Regulation (EC) No 1924/20061. EFSA J 2010; 8: 1688-702.
Clarkson TB. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002; 132: 566S-9S.
Forsythe WA, Green MS, Anderson JJ. Dietary protein effects on cholesterol and lipoprotein concentrations: a review. J Am Coll Nutr 1986; 5: 533-49.
Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998; 128: 209-13.
Ho SC, Woo JL, Leung SS, Sham AL, Lam TH, Janus ED. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 2000; 130: 2590-3.
Proposed International Guidelines for Biomedical Research Involving Human Subjects. The Council for International Organisation of Medical Sciences. Geneva, 1982.
Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-83.
NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
Lichtenstein AH, Appel LJ, Brands M, et al. Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006. Arterioscler Thromb Vasc Biol 2006; 26: 2186-91.
Derosa G, Maffioli P, Salvadeo SA, et al. Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients. Curr Med Res Opin 2009; 25: 1973-83.
Winer BJ. Statistical Principles in Experimental Design. 2nd ed., McGraw-Hill, New York (USA) 1971.
Shige H, Ishikawa T, Higashi K, et al. Effects of soy protein isolate (SPI) and casein on the postprandial lipemia in normolipidemic men. J Nutr Sci Vitaminol (Tokyo) 1998; 44: 113-27.
Vahouny GV, Chalcarz W, Satchitanandam S, Adamson I, Klurfeld DM, Krichevski D. Effect of soy protein and casein intake on intestinal absorption and lymphatic transport of cholesterol and oleic acid. Am J Clin Nutr 1984; 40: 1156-64.
Sirtori CR, Galli G, Lovati MR, Carrara P, Bosisio E, Galli-Kienle M. Effects of dietary proteins on the regulation of liver lipoprotein receptors in rat. J Nutr 1984; 114: 1493-500.
Chon JS, Nestel PJ. Hepatic lipoprotein receptor activity in rat fed casein and soy protein. Atherosclerosis 1985; 56: 247-50.
Lovati MR, Manzoni C, Canavesi A, et al. Soybean protein diet increased low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987; 80: 1498-502.
Gaddi A, Ciarocchi A, Matteucci A, et al. Dietary treatment for familial hypercholesterolemia-differential effects of dietary soy protein according to the apolipoprotein E phenotype. Am J Clin Nutr 1991; 53: 1191-6.
Forsythe WA. Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentration in the gerbil. J Nutr 1986; 116: 1165-71.
Vessby B, Karlstrom B, Lithell H, Gustafsson TB, Werner I. The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy protein in a lipid-lowering diet for hypercholesterolemic patients. Human Nutr Appl Nutr 1982; 36: 179-89.
Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas MC. Postprandial inflammation and endothelial dysfunction. Biochem Soc Trans 2007; 35: 466-9.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe